Operating Income for Henry Schein (HSIC)
According to Henry Schein's latest reported financial statements, the company's current operating income (TTM) is $769.00M USD. Operating income is profit from core operations: revenue minus cost of goods sold and operating expenses (SG&A, R&D). It excludes interest, taxes, and non-operating items, so it isolates how profitable the business itself is before financing and tax decisions. Compare with EBITDA and net income.
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .

HSIC
Currently viewingOperating IncomeSwitch metric
TTM (last 4 quarters)
$769.00M
YoY change
+4.0%
5Y CAGR
+6.0%
Peak year (2022)
$938.00M
Cumulative operating income
$14.67B
Operating Income history chart for Henry Schein (HSIC) from 1994 to 2025
Operating Income history table for Henry Schein (HSIC) from 1994 to 2025
| Fiscal year | Period ended | Reported | Operating Income | YoY |
|---|---|---|---|---|
| 2025 | $758.00M | +4.0% | ||
| 2024 | $729.00M | +2.1% | ||
| 2023 | $714.00M | -23.9% | ||
| 2022 | $938.00M | +9.7% | ||
| 2021 | $854.81M | +50.7% | ||
| 2020 | $567.40M | -22.6% | ||
| 2019 | $732.97M | +5.7% | ||
| 2018 | $693.47M | -19.8% | ||
| 2017 | $864.69M | +5.8% | ||
| 2016 | $817.47M | +6.3% | ||
| 2015 | $768.90M | +7.5% | ||
| 2014 | $715.14M | +5.6% | ||
| 2013 | $677.05M | +6.8% | ||
| 2012 | $634.15M | +8.9% | ||
| 2011 | $582.15M | +8.6% | ||
| 2010 | $535.86M | +15.9% | ||
| 2009 | $462.22M | +4.5% | ||
| 2008 | $442.53M | +14.6% | ||
| 2007 | $386.26M | +27.0% | ||
| 2006 | $304.13M | +15.6% | ||
| 2005 | $263.14M | +18.0% | ||
| 2004 | $222.95M | -4.6% | ||
| 2003 | $233.72M | +18.6% | ||
| 2002 | $197.00M | +33.3% | ||
| 2001 | $147.75M | +15.8% | ||
| 2000 | $127.61M | +7.0% | ||
| 1999 | $119.30M | +24.0% | ||
| 1998 | $96.20M | +54.2% | ||
| 1997 | $62.40M | +110.1% | ||
| 1996 | $29.70M | -3070.0% | ||
| 1995 | -$1.00M | -89.5% | ||
| 1994 | -$9.50M | — |
Operating Income values are taken from Henry Schein's reported income statements (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
The 2025 reading of Henry Schein (HSIC) operating income is $758.00M – edged up 4.0% year-over-year.
Looking at the 2020–2025 (5 years) stretch, Henry Schein operating income compounded at +6.0% per year, sustaining 2 straight years of year-over-year growth.
Between 2022 and 2025, Henry Schein operating income declined 19.2%, falling from $938.00M to $758.00M.
Across the available history, operating income reached its high of $938.00M in 2022 and its low of -$9.50M in 1994.
Among 8 Healthcare peers, Henry Schein (HSIC) ranks 9th; the peer median for operating income is $22.84B.
Henry Schein Operating Income by Year
Henry Schein Operating Income 2025: $758.00M
Henry Schein operating income in 2025 was $758.00M, edged up 4.0% from 2024.
Henry Schein Operating Income 2024: $729.00M
Henry Schein operating income in 2024 was $729.00M, edged up 2.1% from 2023.
Henry Schein Operating Income 2023: $714.00M
Henry Schein operating income in 2023 was $714.00M, declined 23.9% below 2022.
Henry Schein Operating Income 2022: $938.00M
Henry Schein operating income in 2022 was $938.00M, grew 9.7% from 2021. This figure represents the highest annual value in the available history.
Henry Schein Operating Income 2021: $854.81M
Henry Schein operating income in 2021 was $854.81M.
See more financial history for Henry Schein (HSIC).
Sector peers — Operating Income
Companies in the same sector as Henry Schein, ranked by their latest operating income.
| Company | Operating Income | Sector |
|---|---|---|
| Novo Nordisk A/S (NVO) | $127.66B | Healthcare |
| Eli Lilly and Company (LLY) | $29.70B | Healthcare |
| Merck & Co., Inc. (MRK) | $26.78B | Healthcare |
| Johnson & Johnson (JNJ) | $25.60B | Healthcare |
| AbbVie Inc. (ABBV) | $20.09B | Healthcare |
| UnitedHealth Group Incorporated (UNH) | $18.96B | Healthcare |
| AstraZeneca PLC (AZN) | $13.74B | Healthcare |
| Amgen Inc. (AMGN) | $10.68B | Healthcare |
Frequently asked questions
What is Henry Schein's operating income?
- Latest reported operating income for Henry Schein (HSIC) is $769.00M (period ending December 27, 2025).
How has Henry Schein operating income changed year-over-year?
- Henry Schein (HSIC) operating income changed +4.0% year-over-year on the latest annual filing.
What is the long-term growth rate of Henry Schein operating income?
- Henry Schein (HSIC) operating income compound annual growth rate is +6.0% over the most recent 5 years available.
When did Henry Schein operating income hit its highest annual value?
- Henry Schein operating income reached its highest annual value of $938.00M in 2022.
What was Henry Schein operating income in 2024?
- Henry Schein (HSIC) operating income in 2024 was $729.00M.
What was Henry Schein operating income in 2025?
- Henry Schein (HSIC) operating income in 2025 was $758.00M.
Metrics overview
Pick a metric for charts, filings, and peers — each row shows the latest TTM or annual value with year-over-year change.
Explore more
HSIC Overview
Company profile, financial tools, and key metrics
HSIC Revenue Counter
Earns $418.06 every second. See per minute, hour, and day.
HSIC Earnings Counter
Earns $12.62 per second net profit. See per minute, hour, and day.
HSIC Economic Scale
Exceeds Equatorial Guinea's GDP. Compare with world economies.
HSIC What If Invested
What if you had invested $1,000? See historical returns from any date.
HSIC How It Makes Money
Discover visual breakdown of $13.18B in revenue — where it comes from and where it goes.
HSIC Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
HSIC Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
HSIC Daily Price Character
Balanced · 50.2% historical win rate (green days). Streaks & record days.
HSIC Buybacks
9.51% TTM buyback yield. Shareholder yield & SBC comparison.
HSIC Stock Split History
3 splits on record. Dates, ratios, and cumulative multiple.